↓ Skip to main content

Recombinant human growth hormone for treating burns and donor sites

Overview of attention for article published in Cochrane database of systematic reviews, January 2012
Altmetric Badge

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
34 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Recombinant human growth hormone for treating burns and donor sites
Published in
Cochrane database of systematic reviews, January 2012
DOI 10.1002/14651858.cd008990.pub2
Pubmed ID
Authors

Roelf S Breederveld, Wim E Tuinebreijer

Abstract

Recombinant human growth hormone (rhGH) increases protein synthesis, therefore it is used in burns with a total body surface area (TBSA) greater than 40%, where there is frequently an increase in protein breakdown and a decrease in protein synthesis. This change in protein metabolism correlates with poor wound healing of the burn and donor sites.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
Ireland 1 3%
Unknown 32 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 26%
Researcher 6 18%
Student > Bachelor 6 18%
Student > Postgraduate 3 9%
Student > Doctoral Student 1 3%
Other 3 9%
Unknown 6 18%
Readers by discipline Count As %
Medicine and Dentistry 18 53%
Nursing and Health Professions 4 12%
Biochemistry, Genetics and Molecular Biology 1 3%
Sports and Recreations 1 3%
Computer Science 1 3%
Other 2 6%
Unknown 7 21%